This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Nov 30;142(22):1856-1858.

doi: 10.1182/blood.2023022548.

Deironing the spleen with luspatercept

Domenico Girelli^{1

2}, Giacomo Marchi^{1

2}

Affiliations

PMID: 38032674
DOI: 10.1182/blood.2023022548

Free article

Editorial

Deironing the spleen with luspatercept

Domenico Girelli et al. Blood. 2023.

Free article

. 2023 Nov 30;142(22):1856-1858.

doi: 10.1182/blood.2023022548.

Authors

Domenico Girelli^{1

2}, Giacomo Marchi^{1

2}

Affiliations

¹ University of Verona.
² Azienda Ospedaliera Universitaria Integrata Verona.

PMID: 38032674
DOI: 10.1182/blood.2023022548

No abstract available

PubMed Disclaimer

Comment on

Splenic iron decreases without change in volume or liver parameters during luspatercept therapy.
Denton CC, Vodala S, Veluswamy S, Hofstra TC, Coates TD, Wood JC. Denton CC, et al. Blood. 2023 Nov 30;142(22):1932-1934. doi: 10.1182/blood.2023021839. Blood. 2023. PMID: 37704579 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems